全球眼底摄影机市场预测（2025-2030 年）

全球眼底摄影机市场预计将从 2025 年的 599,963,000 美元成长到 2030 年的 758,457,000 美元，复合年增长率为 4.80%。

未来五年，全球眼底摄影机市场预计将迎来显着成长，因为人口老化以及糖尿病、高血压等慢性疾病的日益普遍加剧了视网膜疾病的发生。眼底摄影机是一种配备精密显微镜和闪光灯的专用设备，能够捕捉视网膜、视盘和黄斑的详细影像，从而辅助眼科疾病的诊断和治疗。大众对眼科疾病的认知不断提高，以及人们在眼科保健方面投入的意愿日益增强，都为市场带来了更多机会。然而，其他视网膜成像技术的出现以及政府对设备核准的严格监管，可能会对市场扩张构成挑战。

主要厂商持续的研发活动推动了市场成长，推出了能够提升诊断能力的先进产品。这些创新提高了视网膜成像的准确性和便利性，从而促进了其在临床应用中的普及。此外，部分地区政府强制推行的高品质医疗标准也促使医疗机构用先进的眼底摄影机取代老旧设备，进一步推动了市场成长。

眼底照相机市场按类型、最终用户和地区进行细分。按类型划分，包括散瞳眼底照相机、非散瞳眼底照相机和其他类型的眼底摄影机。非散瞳眼底摄影机因其对患者友好的设计（无需散瞳药物和强光照明）而预计将占据市场主导地位，使其成为医院和诊所的理想选择。其提供清晰视网膜影像的能力提高了诊断准确性，从而推动了该细分市场的成长。另一方面，需要散瞳的散瞳眼底摄影机通常因患者不适而不受青睐，导致其市场份额和增长率较低。按最终用户划分，医院占据了较大的市场份额，因为它们有能力投资先进昂贵的设备，并且拥有提供全面眼科护理的专业医疗机构。诊所，尤其是在新兴市场和低收入国家，预计将保持稳定成长，因为越来越多的验光师开设私人诊所并提供经济实惠的治疗。按地区划分，该市场分布于北美、南美、欧洲、中东和非洲以及亚太地区。北美凭藉其先进的医疗保健基础设施和主要市场参与者的存在，处于主导地位；而亚太地区预计将在印度、中国和印尼等国家医疗保健支出不断增长的推动下实现强劲增长。

卡尔蔡司、OptoMed 和兴和株式会社等主要企业正透过研发投入、产品发布和合作等策略来维持其竞争优势。近期达成的交易和投资凸显了它们对创新和市场扩张的承诺。受人口结构变化、技术进步和医疗投资增加的推动，眼底摄影机市场预计将稳步增长，并成为眼科领域的重要组成部分。

本报告的主要优势：

• 深入分析：获得主要和新兴地区的深入市场洞察，重点关注客户群、政府政策和社会经济因素、消费者偏好、行业垂直领域和其他细分市场。
• 竞争格局：了解全球主要企业的策略倡议，并了解透过正确的策略进入市场的机会。
• 市场驱动因素与未来趋势：探讨影响市场的动态因素和关键趋势及其对未来市场发展的影响。
• 可操作的建议：利用这些见解，在快速变化的环境中製定策略决策，并开拓新的商机和收入来源。
• 受众广泛：适用于Start-Ups、研究机构、顾问公司、中小企业和大型企业，且经济实惠。

报告的主要用途

产业与市场分析、机会评估、产品需求预测、打入市场策略、地理扩张、资本投资决策、法规结构及影响、新产品开发、竞争情报

报告范围：

• 2022-2024年实际数据及2025-2030年预测数据
• 成长机会、挑战、供应链前景、法规结构与趋势分析
• 竞争定位、策略和市场占有率分析
• 各业务板块和地区（包括国家）的收入成长和预测评估
• 公司简介（主要包括策略、产品、财务资讯、重大发展等）

目录

第一章执行摘要

第二章 市场概览

• 市场概览
• 市场定义
• 调查范围
• 市场区隔

第三章 商业情境

• 市场驱动因素
• 市场限制
• 市场机会
• 波特五力分析
• 产业价值链分析
• 政策与法规
• 策略建议

第四章 技术展望

第五章 全球眼底摄影机市场（按类型划分）

• 介绍
• 散瞳眼底眼底摄影机
• 无散瞳的眼底摄影机
• 混合眼底摄影机
• 早产儿视网膜病变（ROP）眼底摄影机
• 彩色眼底摄影机
• 多色眼底摄影机
• 立体眼底摄影机

第六章 全球眼底摄影机市场（依最终用户划分）

• 介绍
• 医院
• 眼科诊所
• 眼科和验光诊所
• 门诊手术中心
• 学术研究机构
• 其他的

第七章 全球眼底摄影机市场（按应用划分）

• 介绍
• 糖尿病视网膜病变
• 老龄化黄斑部病变（AMD）
• 青光眼
• 视网膜血管疾病
• 其他的

第八章 全球眼底摄影机市场（按地区划分）

• 介绍
• 北美洲
  • 美国
  • 加拿大
  • 墨西哥
• 南美洲
  • 巴西
  • 阿根廷
  • 其他的
• 欧洲
  • 德国
  • 法国
  • 英国
  • 西班牙
  • 其他的
• 中东和非洲
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他的
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 印尼
  • 泰国
  • 其他的

第九章 竞争格局与分析

• 主要企业和策略分析
• 市占率分析
• 併购、协议和合作
• 竞争对手仪錶板

第十章：公司简介

• Carl Zeiss Meditec AG
• Kowa Company Ltd.
• Optomed
• Canon Inc.
• Optovue, Incorporated
• NIDEK CO., LTD.
• Optos
• Epipole Ltd.
• Remidio
• TOPCON CORPORATION

第十一章附录

• 货币
• 先决条件
• 基准年和预测年时间表
• 相关人员的主要收益
• 调查方法
• 简称

The Fundus Camera Market will expand from USD 599.963 million in 2025 to USD 758.457 million in 2030, registering a 4.80% CAGR.

The global fundus camera market is projected to experience substantial growth over the next five years, driven by an aging population and the rising prevalence of chronic conditions such as diabetes and hypertension, which contribute to retinal disorders. Fundus cameras, specialized devices with intricate microscopes and flash-enabled cameras, capture detailed images of the retina, optic disc, and macula, aiding in the diagnosis and management of eye diseases. Increased public awareness of eye disorders and a growing willingness to invest in eye treatments are further propelling market opportunities. However, the presence of alternative retinal imaging technologies and stringent government regulations on equipment approvals may pose challenges to market expansion.

Market growth is supported by continuous research and development (R&D) efforts from key players, who are launching advanced products to enhance diagnostic capabilities. These innovations improve the accuracy and ease of retinal imaging, driving adoption in healthcare settings. Government regulations in some regions, mandating high-quality treatment standards, also support market growth by encouraging the replacement of outdated equipment with advanced fundus cameras.

The market is segmented by type, end-user, and geography. By type, it includes mydriatic, non-mydriatic, and other fundus cameras. Non-mydriatic fundus cameras are expected to dominate, owing to their patient-friendly design, which eliminates the need for pupil-dilating drops and bright lights, making them ideal for hospitals and clinics. Their ability to provide detailed retinal images enhances diagnostic precision, supporting segment growth. Mydriatic cameras, requiring pupil dilation, are less preferred due to patient discomfort, resulting in a lower market share and growth rate. By end-user, hospitals hold a significant share due to their capacity to invest in advanced, costly equipment and the presence of specialized eye care facilities offering comprehensive care. Clinics are projected to see steady growth, driven by the increasing number of optometrists opening self-owned practices and offering cost-effective treatments, particularly in emerging and low-income countries. Geographically, the market spans North America, South America, Europe, the Middle East and Africa, and the Asia Pacific. North America leads due to its advanced healthcare infrastructure and major market players, while the Asia Pacific region is expected to exhibit robust growth, fueled by rising healthcare expenditures in countries like India, China, and Indonesia.

Key players, including Carl Zeiss, Optomed, and Kowa Company Ltd., are adopting strategies such as R&D investments, product launches, and partnerships to maintain competitive advantages. Recent deals and investments underscore their commitment to innovation and market expansion. The fundus camera market is set for steady growth, driven by demographic trends, technological advancements, and increasing healthcare investments, positioning it as a vital segment in ophthalmic care.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data from 2022 to 2024 & forecast data from 2025 to 2030
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Fundus Camera Market Segmentation:

By Type

• Mydriatic Fundus Cameras
• Non-Mydriatic Fundus Cameras
• Hybrid Fundus Cameras
• Retinopathy of Prematurity (ROP) Fundus Cameras
• Color Fundus Cameras
• Multicolor Fundus Cameras
• Stereoscopic Fundus Cameras

By End-Users

• Hospitals
• Ophthalmology Clinics
• Ophthalmic & Optometrist Offices
• Ambulatory Surgical Centers
• Academic Research Institutes
• Others

By Application

• Diabetic Retinopathy
• Age-Related Macular Degeneration (AMD)
• Glaucoma
• Retinal Vascular Disorders
• Others

By Geography

• North America
• USA
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• Germany
• France
• United Kingdom
• Spain
• Others
• Middle East and Africa
• Saudi Arabia
• UAE
• Others
• Asia Pacific
• China
• India
• Japan
• South Korea
• Indonesia
• Thailand
• Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

• 2.1. Market Overview
• 2.2. Market Definition
• 2.3. Scope of the Study
• 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Porter's Five Forces Analysis
• 3.5. Industry Value Chain Analysis
• 3.6. Policies and Regulations
• 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL FUNDUS CAMERA MARKET BY TYPE

• 5.1. Introduction
• 5.2. Mydriatic Fundus Cameras
• 5.3. Non-Mydriatic Fundus Cameras
• 5.4. Hybrid Fundus Cameras
• 5.5. Retinopathy of Prematurity (ROP) Fundus Cameras
• 5.6. Color Fundus Cameras
• 5.7. Multicolor Fundus Cameras
• 5.8. Stereoscopic Fundus Cameras

6. GLOBAL FUNDUS CAMERA MARKET BY END-USERS

• 6.1. Introduction
• 6.2. Hospitals
• 6.3. Ophthalmology Clinics
• 6.4. Ophthalmic & Optometrist Offices
• 6.5. Ambulatory Surgical Centers
• 6.6. Academic Research Institutes
• 6.7. Others

7. GLOBAL FUNDUS CAMERA MARKET BY APPLICATION

• 7.1. Introduction
• 7.2. Diabetic Retinopathy
• 7.3. Age-Related Macular Degeneration (AMD)
• 7.4. Glaucoma
• 7.5. Retinal Vascular Disorders
• 7.6. Others

8. GLOBAL FUNDUS CAMERA MARKET BY GEOGRAPHY

• 8.1. Introduction
• 8.2. North America
  • 8.2.1. USA
  • 8.2.2. Canada
  • 8.2.3. Mexico
• 8.3. South America
  • 8.3.1. Brazil
  • 8.3.2. Argentina
  • 8.3.3. Others
• 8.4. Europe
  • 8.4.1. Germany
  • 8.4.2. France
  • 8.4.3. United Kingdom
  • 8.4.4. Spain
  • 8.4.5. Others
• 8.5. Middle East and Africa
  • 8.5.1. Saudi Arabia
  • 8.5.2. UAE
  • 8.5.3. Others
• 8.6. Asia Pacific
  • 8.6.1. China
  • 8.6.2. India
  • 8.6.3. Japan
  • 8.6.4. South Korea
  • 8.6.5. Indonesia
  • 8.6.6. Thailand
  • 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 9.1. Major Players and Strategy Analysis
• 9.2. Market Share Analysis
• 9.3. Mergers, Acquisitions, Agreements, and Collaborations
• 9.4. Competitive Dashboard

10. COMPANY PROFILES

• 10.1. Carl Zeiss Meditec AG
• 10.2. Kowa Company Ltd.
• 10.3. Optomed
• 10.4. Canon Inc.
• 10.5. Optovue, Incorporated
• 10.6. NIDEK CO., LTD.
• 10.7. Optos
• 10.8. Epipole Ltd.
• 10.9. Remidio
• 10.10. TOPCON CORPORATION

11. APPENDIX

• 11.1. Currency
• 11.2. Assumptions
• 11.3. Base and Forecast Years Timeline
• 11.4. Key benefits for the stakeholders
• 11.5. Research Methodology
• 11.6. Abbreviations